In sum, we provide evidence showing that the interaction of α-Syn with the mitochondrial protein import machinery, in particular Tom40, might be an upstream event in α-Syn-induced neurotoxicity and that targeting of this protein might represent a novel therapeutic strategy in PD. The gene discussed is TOMM40; the disease is Parkinson disease.